However, the exact role of SOX2 in mediating SCLC progression of in lung cancer patients has not been fully elucidated due to the limited accessibility of patient tissues for research purposes (Tripathi et al., 2017). This evidence concerns the gene SOX2 and small cell lung carcinoma.